Trial Profile
Effects of Montelukast on Early Life Wheezing
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 10 Sep 2018
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Wheezing
- Focus Therapeutic Use
- 12 Dec 2016 Status changed from active, no longer recruiting to completed.
- 02 Nov 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 20 Feb 2013 Planned end date changed from 1 Jun 2009 to 1 Sep 2020 as reported by ClinicalTrials.gov.